Sales revenues for December 2012

The Board of Directors of Sopharma AD (the “Company”) notifies that for December 2012 Sopharma AD realized decrease of sales revenues of 13% compared to the same period of 2011, including 9% decrease of domestic sales and 17% decrease of export sales. 

During the past twelve months Sopharma AD recorded an increase of sales revenues of 0.4%, including 9% decrease of domestic sales and 5% increase of export sales compared to 2011.